APA (7th ed.) Citation

Darrah, J., Yang, K., Wang, T., Patel, V., Mutebi, A., Atiya, M., . . . Risum, M. (2025). 325 | MATCH‐ADJUSTED COMPARATIVE ANALYSIS OF EPCORITAMAB + R‐DHAX/C OR R‐ICE VERSUS R‐DHAX/C OR R‐ICE IN 2L+ TRANSPLANT‐ELIGIBLE PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA. Hematological oncology, 43, 1. https://doi.org/10.1002/hon.70094_325

Chicago Style (17th ed.) Citation

Darrah, J., et al. "325 | MATCH‐ADJUSTED COMPARATIVE ANALYSIS OF EPCORITAMAB + R‐DHAX/C OR R‐ICE VERSUS R‐DHAX/C OR R‐ICE IN 2L+ TRANSPLANT‐ELIGIBLE PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA." Hematological Oncology 43 (2025): 1. https://doi.org/10.1002/hon.70094_325.

MLA (9th ed.) Citation

Darrah, J., et al. "325 | MATCH‐ADJUSTED COMPARATIVE ANALYSIS OF EPCORITAMAB + R‐DHAX/C OR R‐ICE VERSUS R‐DHAX/C OR R‐ICE IN 2L+ TRANSPLANT‐ELIGIBLE PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA." Hematological Oncology, vol. 43, 2025, p. 1, https://doi.org/10.1002/hon.70094_325.